Targeted therapy for bladder cancer

Bladder cancer is assessed using tissue results, scans and the stage of disease. Laboratory testing may look for changes or markers that could make a tumour more likely to respond to a particular medicine. A targeted medicine may block a growth signal, interfere with a cancer-cell process or help the immune system recognise abnormal cells, depending on the drug.

Treatment may be considered after surgery, alongside another treatment, or when cancer has returned or spread. The choice depends on tumour features, kidney and liver function, previous medicines, other health conditions and your goals. A target test does not guarantee a response, and a result without a target does not by itself determine every treatment option.

Give your team a complete list of medicines, vitamins and supplements. Ask how the treatment is taken, what to do after a missed dose, and whether food or other medicines affect it. Keep appointments for blood tests and reviews; these can identify changes before you feel unwell.

Possible effects depend on the medicine and may include skin changes, diarrhoea, tiredness, appetite changes, blood-pressure changes or effects on the liver, kidneys or heart. Record new symptoms, temperature if advised, and changes in urine or bowel habits. Do not start a new supplement without checking first.

Contact the treatment team promptly for fever, severe diarrhoea, repeated vomiting, yellowing of the skin or eyes, a new rash, reduced urine, unusual bleeding or worsening breathlessness. Seek urgent help for chest pain, severe breathing difficulty, fainting, confusion or signs of a serious allergic reaction.

Ask which tumour feature the medicine targets, whether testing is needed, how it is given, how long treatment may continue, and how response will be assessed. Ask about interactions, fertility or pregnancy considerations, monitoring tests, and what to do if side effects interrupt treatment.